SEC Form 4 · accession 0001127602-18-024061
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark W Kroll
Director
Period of report
Jul 26, 2018
Accepted (ET)
Jul 30, 2018 · 6:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 26, 2018 | A | 1,696 | — | A | 28,459 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest 100% on the first anniversary of the date of grant.
- F2Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.